0001621206-17-000002.txt : 20170525
0001621206-17-000002.hdr.sgml : 20170525
20170525172228
ACCESSION NUMBER: 0001621206-17-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170525
DATE AS OF CHANGE: 20170525
EFFECTIVENESS DATE: 20170525
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Whistler Medical Marijuana Corp
CENTRAL INDEX KEY: 0001621206
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-287527
FILM NUMBER: 17870983
BUSINESS ADDRESS:
STREET 1: 1330 ALPHA LAKE ROAD, UNIT 113
CITY: WHISTLER
STATE: A1
ZIP: V0N 1B1
BUSINESS PHONE: (604) 962-3440
MAIL ADDRESS:
STREET 1: 1330 ALPHA LAKE ROAD, UNIT 113
CITY: WHISTLER
STATE: A1
ZIP: V0N 1B1
D
1
primary_doc.xml
X0707
D
LIVE
0001621206
Whistler Medical Marijuana Corp
1330 ALPHA LAKE ROAD, UNIT 113
WHISTLER
A1
BRITISH COLUMBIA, CANADA
V0N 1B1
(604) 962-3440
BRITISH COLUMBIA, CANADA
None
None
Corporation
true
2013
Christopher
Pelz
1330 Alpha Lake Road, Unit 113
Whistler
A1
BRITISH COLUMBIA, CANADA
V0N 1B1
Executive Officer
Director
Promoter
Pharmaceuticals
Decline to Disclose
- 06b
false
2017-05-10
false
true
false
0
222053
0
222053
US dollar amounts in this filing have been converted from Canadian dollars based on the 0.7314 Bank of Canada noon exchange rate in effect on 5-10-17.
false
2
0
0
0
true
Net proceeds from this offering will be used for general working capital purposes, and as such may be used for payments to officers and directors in the ordinary course, but are not specifically earmarked for such payments.
false
Whistler Medical Marijuana Corp
/s/ Christopher Pelz
Christopher Pelz
President & CEO
2017-05-25